BMC Cancer

BMC Cancer is a prominent open-access, peer-reviewed journal published by Springer Nature as part of the BMC series. With an ISSN of 1471-2407 and a 2026 Impact Factor of 4.6380, the journal holds a Q2 quartile ranking in the JCR, reflecting its solid standing as a respected and widely cited venue within the oncology field. The journal’s scope encompasses all aspects of cancer research, including basic, translational, and clinical studies. It covers a broad range of main topics such as cancer biology, genetics and genomics, epidemiology, prevention, diagnosis, treatment, and survivorship. BMC Cancer welcomes a variety of article types, including original research articles, reviews, methodology articles, short reports, and database articles, with a particular emphasis on studies that offer novel insights or confirmatory findings that advance scientific understanding. The target audience includes academic researchers, clinicians, epidemiologists, and public health professionals engaged in oncology. A notable feature of BMC Cancer is its fully open-access model, ensuring that all published articles are freely and permanently available online immediately upon publication, which maximizes visibility and impact. The journal also offers fast peer review and continuous publication, facilitating rapid dissemination of research findings. As a Q2 journal with a competitive impact factor, BMC Cancer is recognized for its rigorous editorial standards and its role in disseminating significant cancer research to a global audience, making it a valuable resource for the scientific community.